Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2008
09/18/2008WO2008111871A1 Peroral memantine-based medicinal preparation and a method for the production thereof
09/18/2008WO2008111832A1 Method of improving skills with a composition comprising non-digestible saccharide
09/18/2008WO2008111796A1 Polyphenol compounds with modulating neurotransmitter release
09/18/2008WO2008111767A1 Orally bioavailable prodrugs of (+)-3-hydroxymorphinan for parkinson's disease prevention or treatment
09/18/2008WO2008111674A1 Process for production of buprenorphine pharmaceutical preparation to be applied to mouth mucosa
09/18/2008WO2008111669A1 Novel prophylactic and/or therapeutic agent for diabetic neuropathy
09/18/2008WO2008111668A1 Novel prophylactic and/or therapeutic agent for neurogenic pain
09/18/2008WO2008111662A1 A medicament for treating chronic obstructive pulmonary disease
09/18/2008WO2008111634A1 Biomarker specific to brain/nerve or specific to neuronal differentiation
09/18/2008WO2008111632A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative
09/18/2008WO2008111630A1 Pirenoxine-containing suspension-type aqueous preparation
09/18/2008WO2008111604A1 Novel pyrimidine compound having benzyl(heterocyclicmethyl)amine structure and pharmaceutical product containing the same
09/18/2008WO2008111590A2 Ampa and nmda receptor antagonists for neurodegenerative diseases
09/18/2008WO2008111538A1 Magnetic-sensitive material, magnetic-sensitive medicinal agent, and those production methods
09/18/2008WO2008111526A1 Method for production of sugar oxazoline derivative
09/18/2008WO2008111520A1 Gene related to life extension and use thereof
09/18/2008WO2008111497A1 Prophylactic or therapeutic agent for ophthalmic disease associated with oxidative stress, comprising triterpenoid as active ingredient
09/18/2008WO2008111473A1 Glucokinase activator
09/18/2008WO2008111450A1 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor
09/18/2008WO2008111441A1 Pharmaceutical composition
09/18/2008WO2008111440A1 Method for stable storage of reduced coenzyme q10
09/18/2008WO2008111429A1 Disinfectant
09/18/2008WO2008111384A1 Epithelium improving agent
09/18/2008WO2008111300A1 Novel diamide derivative
09/18/2008WO2008111299A1 Novel diamide derivative
09/18/2008WO2008111296A1 Pharmaceutical agent for prevention and treatment of skin disease induced by accelerated keratinization
09/18/2008WO2008111295A1 Agent for prevention and/or treatment of systemic lupus erythematosus
09/18/2008WO2008111271A1 Oral composition for nourishing the hair and stimulating hair growth
09/18/2008WO2008111082A1 Process for the synthesis of ib-meca
09/18/2008WO2008111010A1 Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors
09/18/2008WO2008111009A1 Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
09/18/2008WO2008110928A2 Dual bandwidth time difference of arrival (tdoa) system
09/18/2008WO2008110872A2 Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
09/18/2008WO2008110863A1 Indazole derivatives and their use as vanilloid receptor ligands
09/18/2008WO2008110846A2 Compositions comprising (s)-2-amino-1-(4-chlorophenyl)-1-[4-(1h-pyrazol-4-yl)-phenyl]-ethanol as modulator of protein kinases
09/18/2008WO2008110840A1 Beneficial effects of bacteriophage treatments
09/18/2008WO2008110826A1 Polyaphron topical composition with a corticosteroid
09/18/2008WO2008110819A1 Polyaphron topical composition with vitamin d
09/18/2008WO2008110815A1 Polyaphron topical composition with vitamin d and corticosteroid
09/18/2008WO2008110794A1 Piperidinones useful in the treatment of inflammation
09/18/2008WO2008110793A1 Piperidinones useful in the treatment of inflammation
09/18/2008WO2008110777A2 Modulators of vegf splicing as pro- and anti-angiogenic agents
09/18/2008WO2008110697A2 Use of a compound antagonist to the nk2 receptors of a neurokinine for the preparation of drugs useful for preventing and treating sexual dysfunction
09/18/2008WO2008110691A1 Novel tricyclic derivatives, method for preparing same and pharmaceutical compositions containing same
09/18/2008WO2008110619A1 Powders for reconstitution
09/18/2008WO2008110611A1 Organic compounds and their uses
09/18/2008WO2008110598A1 Tricyclic isoquinoline derivatives for treatment of obesity
09/18/2008WO2008110585A2 Compositions and methods for preventing and treating mucositis and weight loss
09/18/2008WO2008110583A1 Amide compounds and their use as antitumor agents
09/18/2008WO2008110577A1 Time- specific delayed/pulsatile release dosage forms
09/18/2008WO2008110566A1 Compounds which potentiate ampa receptor and uses thereof in medicine
09/18/2008WO2008110534A1 Pharmaceutical compositions of poorly soluble drugs
09/18/2008WO2008110523A1 Imidazo [1,5-a] pyridine derivatives as inhibitors of glutaminyl cyclase
09/18/2008WO2008110491A2 Chemotherapy of neoplastic diseases using combinations of rapamycin and compounds modulating mtor pathway alone or in combination with heat
09/18/2008WO2008110488A1 Malonamides as orexin antagonists
09/18/2008WO2008110374A2 Pellets containing a pharmaceutical substance, method for the production thereof and use of the same
09/18/2008WO2008110351A2 Use of (r) and (s)-2-aryl-propionic acid derivatives as antiseptic agents
09/18/2008WO2008110339A2 Polymorphs of rivastigmine hydrogentartrate
09/18/2008WO2008110337A2 Pharmaceutical composition of quetiapine fumarate
09/18/2008WO2008110323A1 Use of 1-phenyl-3-dimethylamino-propane compounds for the therapy of neuropathy pain
09/18/2008WO2008110196A1 Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors
09/18/2008WO2008110178A2 MANAGEMENT OF ACUTE CEREBRAL INFARCTION BY SINGLE MEGADOSE OF CLOPIDOGREL (750-1500mg)
09/18/2008WO2008110080A1 Medical composition containing cyclodextrin inclusion compound of cefixime and its preparation method
09/18/2008WO2008110079A1 Medical composition containing cyclodextrin inclusion compound of cefdinir and its preparation method
09/18/2008WO2008110065A1 Compositions and methods for treating cancer
09/18/2008WO2008110062A1 Compounds with partial agonist activity of pparϝ and application thereof
09/18/2008WO2008110050A1 THE USE OF GINSENOSIDE Rg1, ITS METABOLITES GINSENOSIDE Rh1 AND PpT
09/18/2008WO2008110035A1 A pharmaceutical composition containing inclusion compound of cyclodextrin and adefovir dipivoxil and preparative method thereof
09/18/2008WO2008110034A1 3-hydroxy fatty acid and its derivatives for improving of learning and/or memory of subjects
09/18/2008WO2008110008A1 Amide derivatives as calcium channel blockers
09/18/2008WO2008109997A1 Procaspase 8-mediated disease targeting
09/18/2008WO2008109996A1 Assessing chemotherapy resistance of colorectal tumors by determining sparc hypermethylation
09/18/2008WO2008109994A1 Inhibitors of histone deacetylase
09/18/2008WO2008109991A1 Inhibitors of carnitine palmitoyltransferase and treating cancer
09/18/2008WO2008109943A1 Phenyl amino pyrimidine compounds and uses thereof
09/18/2008WO2008094054A3 6, 8-dichlorchroman-3-yl-l, 3-dihydroimidazole-2-thione derivatives and their use for the treatment of cardiovascular disorders
09/18/2008WO2008092816A3 Novel polymorphic forms of n-piperidino-5-(4-chlorophenyl)-1(2, 4-dichlorphenyl)-4-methyl-3-pyrazolecarboxamide
09/18/2008WO2008091620A3 Combination therapy comprising romidepsin and i.a. bortezomib
09/18/2008WO2008091375A9 Attenuated salmonella as a delivery system for sirna-based tumor therapy
09/18/2008WO2008090286A3 Derivatives of imidazo, pyrimido and diazepine pyrimidine-dione, and use thereof as a drug
09/18/2008WO2008089984A3 Process for the preparation of ezetimibe and derivatives thereof
09/18/2008WO2008089052A3 N-substituted glycine derivatives: hydroxylase inhibitors
09/18/2008WO2008088987B1 Treatment of pain with naloxone
09/18/2008WO2008088917A3 Methods of using pyridinium and thiazolium compounds as reagents, diagnostic compounds and therapeutic agents
09/18/2008WO2008088900A9 Polymorphic forms of rimonabant base and processes for preparation thereof
09/18/2008WO2008088692A3 Spirochromanon derivatives
09/18/2008WO2008087461A3 Use of kynurenic acid and derivatives thereof in the treatment of conditions of the gastrointestinal tract accompanied by hypermotility and inflammation or gout or multiple sclerosis
09/18/2008WO2008087340A3 Use of modified oligo-β-(1,3)-glucanes for treating diseases of the immune system, oligo-β- (1,3v-glucane-(1,3)- mannose, oligo-β-(1,3)-glucane-(1,3)- mannitol and derivatives thereof, methods for preparing the same and drugs containing them
09/18/2008WO2008087323A8 Galenic form for the transmucosal delivery of paracetamol
09/18/2008WO2008087278A3 5-alkyloxy-indolin-2-one derivatives, preparation thereof and application thereof in therapy as selective ligands of v2 vasopressin receptors
09/18/2008WO2008086834A3 Pharmaceutical composition for treating incontinence
09/18/2008WO2008085927A3 Methods, compositions, and kits for the treatment of pain
09/18/2008WO2008085808A3 Method of treating hyperesthesia, paresthesia, dolor, and pruritus caused by insect stings or noxious weeds or plants using avermectin compound
09/18/2008WO2008085508A3 Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
09/18/2008WO2008085484A3 Treatment of inflammatory bowel disease with enteric coated formulations comprising 5-aminosalicylic acid or 4-aminosalicylic acid
09/18/2008WO2008084241A3 Use of aminolevulinic acid and derivatives thereof
09/18/2008WO2008082637A9 Composition and methods for modulating a kinase cascade
09/18/2008WO2008081041A3 Amorphous and crystalline forms of rivastigmine hydrogentartrate
09/18/2008WO2008076954A3 Heterocycle compounds and methods of use thereof
09/18/2008WO2008074832A3 Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase ( scd)
1 ... 3078 3079 3080 3081 3082 3083 3084 3085 3086 3087 3088 3089 3090 3091 3092 3093 3094 3095 3096 3097 3098 ... 7860